Internal Medicine
Online ISSN : 1349-7235
Print ISSN : 0918-2918
ISSN-L : 0918-2918
47 巻, 1 号
選択された号の論文の16件中1~16を表示しています
ORIGINAL ARTICLES
  • Tomoko Shiga, Kiyoshi Owada, Tatsuo Hoshino, Hikaru Nagahara, Keiko Sh ...
    2008 年 47 巻 1 号 p. 1-6
    発行日: 2008年
    公開日: 2008/01/01
    ジャーナル オープンアクセス
    Objective The aim of this study is to identify risk factors for asymptomatic cerebral infarction (ACI) in the general Japanese population.
    Materials and Methods A total of 634 subjects (272 men aged 55.4±8.8 years and 362 women aged 55.2±8.5 years) who visited the Health Management Center at Aoyama Hospital (Tokyo, Japan) from January 2004 through January 2005 for an annual brain dry dock examination were analyzed. We evaluated 21 risk factors for ACI by multivariate logistic regression analysis.
    Results Abnormal or potentially abnormal conditions were detected in 258 subjects (40.7% of all subjects who had an annual check-up program for brain disease). The most frequent abnormal finding was ACI, which was observed in 208 subjects. The significant risk factors for ACI, as determined by multivariate logistic analysis, were age (P <0.01), hypertension (P <0.01), and hypertensive vascular changes in the fundus (P <0.05).
    Conclusion The hypertensive vascular abnormalities in the fundus might be a risk factor for ACI independent of age and hypertension.
  • Hideto Sako, Shin-ichiro Miura, Atsushi Iwata, Hiroaki Nishikawa, Akir ...
    2008 年 47 巻 1 号 p. 7-13
    発行日: 2008年
    公開日: 2008/01/01
    ジャーナル オープンアクセス
    Background Although restenosis after successful coronary stenting is associated with changes in adhesion molecules and chemokines, it is unclear whether the differential effects of these molecules between a bare metal stent (BMS) and sirolimus-eluting stent (SES) may help to prevent coronary restenosis. The aim of this clinical study was to compare the expression levels of those molecules after elective placement of either a BMS or SES.
    Methods and Results The subjects included 32 consecutive patients with stable angina who had undergone successful coronary stenting and who randomly received either a BMS (n=16) or SES (n=16). Quantitative angiographic analysis 6 months after stenting showed that the minimal lumen diameter was significantly greater in the SES as compared to the BMS group, while the percent diameter stenosis and in-stent lumen loss were significantly lower. Plasma monocyte chemotactic protein-1 (MCP-1) increased significantly after 14 days and 6 months and monocyte CCR2 expression increased 24 hr and 48 hr after stenting in the BMS but not the SES group. Changes in plasma MCP-1 (ΔMCP-1) within 6 months after stenting correlated significantly with in-stent lumen loss. The ΔMCP-1 (between 6 months and baseline) was significantly related only to the lumen loss (r=0.443, p=0.023), which suggests that the reduction of MCP-1 is the best contributor to decreased lumen loss.
    Conclusions These data suggest that reduction in MCP-1 production by SES may be one mechanism to prevent restenosis after coronary stenting.
  • Tatsuji Enomoto, Arata Azuma, Aki Matsumoto, Takahito Nei, Kazue Fujit ...
    2008 年 47 巻 1 号 p. 15-20
    発行日: 2008年
    公開日: 2008/01/01
    ジャーナル オープンアクセス
    Background Pneumocystis jiroveci pneumonia (PCP) is a potentially fatal complication in interstitial pneumonia patients receiving glucocorticoid therapy. Prophylaxis of PCP during glucocorticoid therapy is an important issue in the treatment of interstitial pneumonia.
    Objective We evaluated the prophylactic effect of sulfamethoxasole-trimethoprim (TMP-SMX) in interstitial pneumonia patients receiving glucocorticoids.
    Methods We retrospectively analyzed 74 interstitial pneumonia patients who received glucocorticoid therapy.
    Results Seven of the 74 patients developed PCP. At the time of diagnosis of PCP, the mean duration of glucocorticoid therapy was 71 days and the mean daily dose of prednisolone was 37 mg. Among the 7 patients, the circulating CD4+ lymphocyte count was 370 /μl on average and it was over 200 /μl in 3 cases. The PCP patients showed a significant reduction of the lymphocyte count at 4 weeks after initiation of steroid therapy. None of the patients who received prophylactic TMP-SMX therapy developed PCP even if the CD4+ lymphocyte count was less than 200 /μl.
    Conclusion Interstitial pneumonia patients receiving glucocorticoid therapy can benefit from TMP-SMX prophylaxis against PCP. Development of PCP cannot be ruled out in patients with a CD4+ lymphocyte count of greater than 200 /μl.
  • Youichi Yanagawa, Kouichirou Nishi, Toshihisa Sakamoto
    2008 年 47 巻 1 号 p. 21-23
    発行日: 2008年
    公開日: 2008/01/01
    ジャーナル オープンアクセス
    Purpose The possibility that hyperammonemia may be associated with generalized convulsion (GC) was retrospectively investigated.
    Methods Subjects comprised 17 patients with GC who were transported to our department and underwent analysis of serum biochemistry, including ammonia, since October 2004.
    Results Causes of convulsion included intracranial lesions (n=8), endocrine diseases (n=2), epilepsy (n=2) and others (n=5). Ammonia levels in all cases exceeded the upper limit of normal range. Ammonia levels in 8 subjects were re-checked on hospital day 2, and all were lower than levels on hospital day 1 without any treatment for hyperammonemia.
    Conclusion GC itself appears to be associated with hyperammonemia. Although hyperammonemia is also known to induce convulsion, biochemical analysis immediately after GC is not useful for diagnosing hyperammonemia-induced convulsion.
  • Yasuharu Tokuda, Sachiko Ohde, Osamu Takahashi, Masaaki Shakudo, Haruo ...
    2008 年 47 巻 1 号 p. 25-31
    発行日: 2008年
    公開日: 2008/01/01
    ジャーナル オープンアクセス
    Objectives Our aim was to analyze the incidence of new onset chest symptoms for the period of a month and to evaluate the possible association of these chest symptoms with demographic, socioeconomic or clinical characteristics.
    Design Prospective observational cohort study using a self-reported health diary among subjects without baseline chest diseases.
    Setting A nationally representative sample of households in Japan.
    Participants Of a total 3,568 subjects from the study recruitment sample, 3,477 participants completed the diary; of these, 127 participants with active chest diseases at baseline were excluded and the remaining 3,350 participants were analyzed.
    Measurements and Results The mean number of episodes of chest symptoms was 1.19 with 95% confidence interval (CI) of 1.0-2.0 and the incidence was 21% (95% CI, 10-30%). Cough was the most frequent chest symptom with the mean number of episodes of 1.14 and the prevalence of 20%. Chest pain, dyspnea, palpitation, and wheezing were identified in less than 1%. Associated factors for cough were younger age, unemployment, and poor physical quality of life. Associated factors for chest pain included older age, living in smaller cities, unemployment, higher educational attainment, and poor physical and mental quality of life.
    Conclusions Chest symptoms are common in the Japanese general population. Cough is the most frequent symptom, followed by chest pain. Younger age, unemployment, and poor physical quality of life are significantly associated with cough.
CASE REPORTS
PICTURES IN CLINICAL MEDICINES
feedback
Top